SNDX icon

Syndax Pharmaceuticals
SNDX

Overview Fund Activity

57 hedge funds and large institutions have $79.8M invested in Syndax Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.

Holders
57
Holders Change
+12
Holders Change %
+26.67%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
15
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
1
EverPoint Asset Management
Connecticut
$1.43M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$16.8M
3
Millennium Management
3
Millennium Management
New York
$717K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.8M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$1.61M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$10.6M
2
Jennison Associates
2
Jennison Associates
New York
$672K
3
ACH
3
ArrowMark Colorado Holdings
Colorado
$1.91M
4
GE
4
General Electric
Ohio
$0
5
EC
5
EcoR1 Capital
California
$1.96M
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
51
UBS Group
Switzerland
$6K 808 -8,189 -91%
Bank of America
52
Bank of America
North Carolina
$5K 647 -201 -24%
MAM
53
Meeder Asset Management
Ohio
$2K 216 +216 New
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$2K 272 +272 New
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K 97 +97 New
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$466 65 -256 -80%
GE
57
General Electric
Ohio
– – -47,945 Closed
AA
58
ALPS Advisors
Colorado
– – -22,669 Closed
LCM
59
Laurion Capital Management
New York
– – -20,091 Closed
Citigroup
60
Citigroup
New York
$0 4 -380 -99%
1 2
3